# Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

> **NCT00690378** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 137 (actual)

## Conditions studied

- Complicated Urinary Tract Infection

## Interventions

- **DRUG:** NXL104/ceftazidime
- **DRUG:** Imipenem/Cilastatin

## Key facts

- **NCT ID:** NCT00690378
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 137 (ACTUAL)
- **Last updated:** 2018-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00690378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00690378, "Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00690378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*